Actinic cheilitis: What is the best treatment?


This review of treatments for actinic cheilitis included 29 mainly observational studies providing little evidence to identify the best treatment approaches.

[read the full story...]

Anti-inflammatory drugs for depression: new review points to benefits, but more research needed


Helge Hasselmann highlights a recent systematic review of anti-inflammatory drugs for depression, which concludes that NSAIDs, in particular celecoxib, decreases depressive symptoms without increased risk of adverse effects. However, the meta-analysis has a number of draw-backs, which make the study findings far from convincing.

[read the full story...]

No evidence for the use of aspirin, steroids or NSAIDs for the treatment of Alzheimer’s disease


Alzheimer’s disease affects 1-2% of people aged 65-70 and approximately 20% of those over 80 years. As our population ages, the condition is on the increase and it’s estimated that 2030, an estimated 7.7 million Americans aged 65 and older will have Alzheimer’s disease. We do not yet know exactly how and why Alzheimer’s disease [read the full story…]